Aspen Pharmacare. Down 37% From 3rd & Final Sell Call
The final call was on the peak of 29 September. Looking back, good call (hope it helped!).
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
相关出版物
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。